Indication of allogenic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in first remission: Retrospective analysis

Indication of allogenic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in first remission: Retrospective analysis - Allogenic HCT for Ph-negative ALL

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016287

Enrollment

100

Registered

2015-01-21

Start date

2015-01-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adults with philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in first remission

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria for this study: (1) diagnosis of Philadelphia chromosome-negative B-cell ALL according to WHO classification (2008) between January 2001 and October 2014; (2) ages >= 16 and <= 70 years; (3) achievement of first remission

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Event free survival of chemotherapy alone or allogenic HCT	—

Countries

Japan

Contacts

Public ContactAkira Yokota

Chiba Aoba Municipal Hospital Department of Hematology

taroyok@gmail.com043-227-1131

Outcome results